These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 19916796)
1. Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings. Becquet R; Ekouevi DK; Arrive E; Stringer JS; Meda N; Chaix ML; Treluyer JM; Leroy V; Rouzioux C; Blanche S; Dabis F Clin Infect Dis; 2009 Dec; 49(12):1936-45. PubMed ID: 19916796 [TBL] [Abstract][Full Text] [Related]
2. [Preventing the transmission of HIV-1 from mother to child in Africa in the year 2000]. Castetbon K; Leroy V; Spira R; Dabis F Sante; 2000; 10(2):103-13. PubMed ID: 10960807 [TBL] [Abstract][Full Text] [Related]
3. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial. Kesho Bora Study Group Clin Infect Dis; 2012 Aug; 55(3):449-60. PubMed ID: 22573845 [TBL] [Abstract][Full Text] [Related]
4. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983 [TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS; Dokubo EK; Sint TT Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370 [TBL] [Abstract][Full Text] [Related]
6. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries. Scarlatti G AIDS Rev; 2004; 6(2):67-78. PubMed ID: 15332429 [TBL] [Abstract][Full Text] [Related]
7. Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study. Kilewo C; Karlsson K; Massawe A; Lyamuya E; Swai A; Mhalu F; Biberfeld G; J Acquir Immune Defic Syndr; 2008 Jul; 48(3):315-23. PubMed ID: 18344879 [TBL] [Abstract][Full Text] [Related]
8. Prevention of perinatal HIV transmission during pregnancy. McGowan JP; Shah SS J Antimicrob Chemother; 2000 Nov; 46(5):657-68. PubMed ID: 11062184 [TBL] [Abstract][Full Text] [Related]
9. Prevention of mother-to-child transmission of HIV infection. Thorne C; Newell ML Curr Opin Infect Dis; 2004 Jun; 17(3):247-52. PubMed ID: 15166829 [TBL] [Abstract][Full Text] [Related]
10. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. Palombi L; Marazzi MC; Voetberg A; Magid NA AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755 [TBL] [Abstract][Full Text] [Related]
11. Antiretroviral drugs to prevent mother-to-child transmission of HIV during breastfeeding. Shetty AK; Maldonado Y Curr HIV Res; 2013 Mar; 11(2):102-25. PubMed ID: 23432487 [TBL] [Abstract][Full Text] [Related]
12. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. ; de Vincenzi I Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire. Jamieson DJ; Sibailly TS; Sadek R; Roels TH; Ekpini ER; Boni-Ouattara E; Karon JM; Nkengasong J; Greenberg AE; Wiktor SZ J Acquir Immune Defic Syndr; 2003 Dec; 34(4):430-6. PubMed ID: 14615662 [TBL] [Abstract][Full Text] [Related]
14. Prevention of mother-to-child HIV-1 transmission in Burkina Faso: evaluation of vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance. Sagna T; Bisseye C; Compaore TR; Kagone TS; Djigma FW; Ouermi D; Pirkle CM; Zeba MT; Bazie VJ; Douamba Z; Moret R; Pietra V; Koama A; Gnoula C; Sia JD; Nikiema JB; Simpore J Glob Health Action; 2015; 8():26065. PubMed ID: 25630709 [TBL] [Abstract][Full Text] [Related]
15. Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000. Dabis F; Leroy V; Castetbon K; Spira R; Newell ML; Salamon R AIDS; 2000 May; 14(8):1017-26. PubMed ID: 10853984 [TBL] [Abstract][Full Text] [Related]
17. Exclusive breastfeeding among women taking HAART for PMTCT of HIV-1 in the Kisumu Breastfeeding Study. Okanda JO; Borkowf CB; Girde S; Thomas TK; Lecher SL BMC Pediatr; 2014 Nov; 14():280. PubMed ID: 25380718 [TBL] [Abstract][Full Text] [Related]
18. Advances in therapy for the prevention of HIV transmission from mother to child. Moretton MA; Bertera F; Lagomarsino E; Riedel J; Chiappetta DA; Höcht C Expert Opin Pharmacother; 2017 May; 18(7):657-666. PubMed ID: 28398096 [TBL] [Abstract][Full Text] [Related]
19. Pregnancy Profile and Infant Outcomes Among HIV Infected Women Who Delivered in Cipto Mangunkusumo Hospital. Indarti J; Yunihastuti E; Kurniati N; Aprilia B; Pamungkas DT; Chiprion AT; Ginting MA; Rizal S; Dewi C; Handayani L Acta Med Indones; 2020 Jan; 52(1):55-62. PubMed ID: 32291372 [TBL] [Abstract][Full Text] [Related]
20. HIV-1 Early Infant Diagnosis is an Effective Indicator of the Prevention of Mother-to-Child Transmission Program Performance: Experience from Cameroon. Saounde Temgoua EM; Nkenfou CN; Zoung-Kanyi Bissek AC; Fokam J; Billong SC; Sosso SM; Tangipumdu C; Elong EL; Domkan I; Colizzi V Curr HIV Res; 2015; 13(4):286-91. PubMed ID: 25845391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]